The integrated care pathway for managing post stroke patients (iCaPPS©) in public primary care Healthcentres in Malaysia: impact on quality adjusted life years (QALYs) and cost effectiveness analysis

Table 7 Incremental Cost Effectiveness Ration for Clinical Outcomes

Variables	Changes after 24-weeks		Incremental Cost (MYR) (Cost _A-Cost _B)	Incremental effectiveness	ICER (MYR per unit reduction or gain)	% GDP
Variables	iCaPPS^©	Conventional Care	Incremental Cost (MYR) (Cost _A-Cost _B)	Incremental effectiveness	ICER (MYR per unit reduction or gain)	% GDP
Systolic blood pressure (mmHg)	0.61	−2.23		2.84	92.65	0.3
Diastolic blood pressure (mmHg)	0.16	−1.12		1.28	205.56	0.7
Total cholesterol (mmol/L)	−0.24	−0.05	263.12	0.19	1384.04	4.5
LDL-cholesterol (mmol/L)	−0.27	− 0.06		0.21	1252.95	4.0
Functional status (BI scores)	1.77	0.94		0.83	317.01	1.0
Quality Adjusted Life Years (QALY)	0.55	0.32		0.23	1144.00	3.7

Cost _A = MYR790.34, Cost _B = MYR527.22
BI Barthel Index, GDP Gross Domestic Per capita income (for 2012: MYR 30956.00), iCaPPS© Integrated Care for Post Stroke, QALY Quality Adjusted Life Years

ISSN: 1471-2318